Living With Chronic Lymphocytic Leukemia (CLL)
May 18, 2022
We invite you to learn more about:
- Treatment goals for a chronic disease
- New and emerging therapies for CLL
- Side-effect management
- The importance of open communication with your healthcare team
Stephen E. Spurgeon, MD
Associate Professor of Medicine
School of Medicine
Oregon Health & Science University
Hematology/Oncology
Portland, OR
Program Support
Support for this program is provided by Genentech, Inc. & Biogen, Eli Lilly and Company, and Pharmacylics, An AbbVie Company & Janssen Biotech.
White
John Crispino
Crispino-John_web_SQ_dam_file_163231.png
FDA Approves New Formulation of Important Childhood Leukemia Drug
Leukemia Resized 3_dam_file_129911.jpg
The Leukemia & Lymphoma Society Launches First-of-Its-Kind Global Master Clinical Trial for Pediatric Acute Leukemia
f-62-21-6300014_DBWOz4Ih_LLS_190601-3301-Edit_dam_file_143916.jpg